Search Results
Dubermatinib 25 mg | 98.65%
TargetMol
Dubermatinib 10 mg | 98.65%
TargetMol
Dubermatinib 2 mg | 98.65%
TargetMol
PFI-2 100 mg | Purity Not Available
TargetMol
PFI-2 is an effective, specific and cell-active lysine methyltransferase SETD7 inhibitor (Ki/IC50: 0.33/2 nM), 1000-fold selectivity over other methyltransferases and other non-epigenetic targets.
More Information Supplier PagePJ34 hydrochloride 100 mg | 98.00%
TargetMol
PJ34 hydrochloride 200 mg | 98.00%
TargetMol
Ibudilast 100 mg | Purity Not Available
TargetMol
Ibudilast(KC-404;AV-411;MN-166) is a relatively nonselective phosphodiesterase inhibitor. It is approved for use as an anti-inflammatory in Japan.
More Information Supplier PageMaribavir 25 mg | 99.85%
TargetMol
Maribavir is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of the viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV […]
More Information Supplier PageMaribavir 1 mg | 99.85%
TargetMol
Maribavir is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of the viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV […]
More Information Supplier Page
